文献速递心脑血管急症重症综合管理与镇静镇痛

心肌肌钙蛋白T对心源性休克接受VA-ECMO治疗患者预后的预测价值:连续5年回顾性研究

[Value of cardiac troponin T in predicting the prognosis of patients with cardiogenic shock receiving veno-arterial extracorporeal membrane oxygenation treatment: a consecutive 5-year retrospective study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论心源性休克接受VA-ECMO患者ECMO后2天cTnT下降率<40.0%与ICU死亡独立相关,AUC 0.704,敏感性86.7%,特异性52.4%。

该单中心回顾性研究纳入2015年3月至2020年5月南京医科大学第一附属医院72例接受VA-ECMO的心源性休克患者,ICU死亡率41.7%。死亡组ECMO后2天和3天cTnT水平显著高于生存组,cTnT下降率显著低于生存组。多因素Logistic回归显示ECMO前心脏骤停(OR=4.564,95%CI 1.212-17.193,P=0.025)和ECMO后2天cTnT下降率(OR=1.617,95%CI 1.144-4.847,P=0.026)是ICU死亡的独立预后危险因素。ROC分析显示ECMO后2天cTnT下降率对ICU死亡有一定预测价值,AUC 0.704(95%CI 0.584-0.824),最佳诊断阈值40.0%,敏感性86.7%,特异性52.4%,阳性预测值66.9%,阴性预测值89.1%。

要点

  • 72例心源性休克接受VA-ECMO患者中,ICU死亡30例(41.7%),死亡组ECMO后2天cTnT下降率中位数17.3%,显著低于生存组36.8%(P<0.05)。
  • ECMO后2天cTnT下降率是ICU死亡的独立危险因素(OR=1.617,95%CI 1.144-4.847,P=0.026),ECMO前心脏骤停OR=4.564(95%CI 1.212-17.193,P=0.025)。
  • ECMO后2天cTnT下降率预测ICU死亡的最佳阈值为40.0%,敏感性86.7%,特异性52.4%,阳性预测值66.9%,阴性预测值89.1%。
  • 死亡组ECMO后2天cTnT中位数6 373.5 ng/L、3天6 202.0 ng/L,均显著高于生存组的1 760.5 ng/L和1 678.0 ng/L(均P<0.05)。

适用人群与场景

  • 2015年3月至2020年5月南京医科大学第一附属医院收治的心源性休克并接受V-A ECMO治疗的患者,共72例。

研究设计与关键结果

  • 单中心回顾性研究,纳入72例接受V-A ECMO的心源性休克患者,ICU死亡30例(41.7%),生存42例。
  • 死亡组与生存组比较:APACHE II评分32(30,34)vs. 29(25,30),ECMO前心脏骤停发生率70.0% vs. 31.0%,ECMO期间有创机械通气比例96.7% vs. 66.7%,连续性肾脏替代治疗比例83.3% vs. 42.9%,差异均有统计学意义(均P<0.05)。
  • ECMO后2天cTnT:死亡组6 373.5(898.3,15 251.5)ng/L vs. 生存组1 760.5(933.0,4 257.8)ng/L;3天:死亡组6 202.0(758.9,16 554.3)ng/L vs. 生存组1 678.0(623.3,3 407.8)ng/L,均P<0.05。
  • ECMO后2天cTnT下降率:死亡组17.3%(-44.2%,34.7%)vs. 生存组36.8%(18.1%,60.6%);3天:死亡组32.4%(-30.0%,55.5%)vs. 生存组53.2%(38.3%,72.3%),均P<0.05。
  • 多因素Logistic回归:ECMO前心脏骤停OR=4.564(95%CI 1.212-17.193,P=0.025),ECMO后2天cTnT下降率OR=1.617(95%CI 1.144-4.847,P=0.026),均为ICU死亡的独立预后危险因素。
  • ROC曲线:ECMO后2天cTnT下降率预测ICU死亡的AUC=0.704(95%CI 0.584-0.824),最佳诊断阈值40.0%,敏感性86.7%,特异性52.4%,阳性预测值66.9%,阴性预测值89.1%。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ECMO后2天cTnT下降率是接受V-A ECMO的心源性休克患者ICU死亡的独立危险因素。
  • 作者认为ECMO后2天cTnT下降率对ICU死亡有一定预测价值,最佳阈值为40.0%。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the changing trend of cardiac troponin T (cTnT) in patients with cardiogenic shock (CS) receiving veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and its predictive value.

METHODS: A retrospective study was conducted. The data of patients with CS receiving V-A ECMO admitted to the First Affiliated Hospital of Nanjing Medical University from March 2015 to May 2020 were enrolled. The baseline data, ECMO related parameters, serum cTnT levels at 1, 2, 3 days after ECMO and intensive care unit (ICU) prognosis were recorded. The parameters with clinical significance and significant difference in univariate analysis were analyzed by binary multivariate Logistic regression analysis. Meanwhile, receiver operating characteristic (ROC) curve was drawn, area under ROC curve (AUC) was analyzed, and the threshold, sensitivity and specificity of serum cTnT level and its reduction rate for predicting clinical outcome were evaluated.

RESULTS: A total of 72 patients were enrolled, of which 42 survived and 30 died at ICU discharge, and the ICU mortality was 41.7%. Univariate analysis results: compared with the survival group, the patients in the death group had higher acute physiology and chronic health evaluation II (APACHE II) score [32 (30, 34) vs. 29 (25, 30)], and the incidence of cardiac arrest before ECMO (70.0% vs. 31.0%), the ratios of invasive mechanical ventilation and continuous renal replacement therapy during ECMO were higher (96.7% vs. 66.7%, 83.3% vs. 42.9%), and the differences were statistically significant (all P < 0.05). Serum cTnT levels (ng/L) at 2 days and 3 days after ECMO in the death group were significantly higher than those in the survival group [2 days: 6 373.5 (898.3, 15 251.5) vs. 1 760.5 (933.0, 4 257.8), 3 day: 6 202.0 (758.9, 16 554.3) vs. 1 678.0 (623.3, 3 407.8), both P < 0.05], and the decrease rates of cTnT within 2 days and 3 days after ECMO were significantly lower than those in the survival group [2 days: 17.3% (-44.2%, 34.7%) vs. 36.8% (18.1%, 60.6%), 3 days: 32.4% (-30.0%, 55.5%) vs. 53.2% (38.3%, 72.3%), both P < 0.05]. Binary multivariate Logistic regression analysis showed that cardiac arrest before ECMO [odds ratio (OR) = 4.564, 95% confidence interval (95%CI) was 1.212-17.193, P = 0.025] and the decrease rate of cTnT level within 2 days after ECMO (OR = 1.617, 95%CI was 1.144-4.847, P = 0.026) were independent prognostic risk factors for the ICU death of CS patients receiving V-A ECMO. ROC curve analysis showed that the decline rate of cTnT within 2 days after ECMO transfer had a certain predictive value for the ICU death of CS patients receiving V-A ECMO. The AUC was 0.704 (95%CI was 0.584-0.824). The optimal diagnostic threshold was 40.0%, the sensitivity was 86.7%, the specificity was 52.4%, the positive predictive value was 66.9%, and the negative predictive value was 89.1%.

CONCLUSIONS: The early decline rate of cTnT in CS patients who received V-A ECMO treatment in death group was lower than that of survival patients. The cTnT decline rate 2 days after ECMO was an independent risk factor for the death of such patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li W, Chen X, Mei Y, et al. [Value of cardiac troponin T in predicting the prognosis of patients with cardiogenic shock receiving veno-arterial extracorporeal membrane oxygenation treatment: a consecutive 5-year retrospective study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33081896. doi:10.3760/cma.j.cn121430-20200630-00494

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。